MEDP - NASDAQ
Medpace Holdings, Inc.
$450.81
+1.2%Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
At a Glance
Live Snapshotmedp
Other Non-Cash Items
Last Annual Value
23.09M
3-Year CAGR
13%
5-Year CAGR
12%
10-Year CAGR
7%
Medpace Holdings, Inc. Competitors Analysis of Other Non-Cash Items
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Medpace Holdings, Inc. NASDAQ:MEDP | 23.09M | 1.1% | 7.2% | 6.5% | |
 Centene Corporation NYSE:CNC | 9.52B | 159.3% | N/A | N/A | |
 Tempus AI, Inc. NASDAQ:TEM | 129.31M | 211.4% | 73.5% | N/A | |
 Waters Corporation NYSE:WAT | 0.00 | N/A | N/A | N/A | |
 Quest Diagnostics Incorporated NYSE:DGX | 27.00M | -13.7% | N/A | -17.5% | |
 Illumina, Inc. NASDAQ:ILMN | -7.00M | N/A | N/A | N/A | |
2.60M | -21.6% | N/A | -0.7% | ||
 Tenet Healthcare Corporation NYSE:THC | 1.19B | 567.0% | N/A | 0.5% | |
 Hologic, Inc. NASDAQ:HOLX | 269.30M | 12.5% | 65.9% | 26.8% |
Medpace Holdings, Inc. Fair Value Envelope
Related Guides
Continue your MEDP research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.